Antibiyotik İlaç Zehirlenmeleri
Synopsis
Antibiyotik gruplarının zehirlenme ve advers etkilerinin ele alındığı bu çalışmada, antibiyotiklerin genel olarak geniş terapötik aralığa sahip olduğu ve fatal toksisitenin nadir görüldüğü belirtilmektedir. Sülfanamidler kristalüri, methemoglobulinemi ve ciddi cilt reaksiyonlarına yol açabilirken, tedavisinde lavaj ve metilen mavisi önerilir. Kinolonlar tendinit, tendon rüptürü, QT uzaması ve SSS eksitasyonu gibi etkiler gösterir. Beta-laktam grubundan penisilinler hipersensitivite, Hoigne sendromu, Jarisch-Herxheimer reaksiyonu ve yüksek dozda nöbet riskine; sefalosporinler ise disülfiram benzeri reaksiyonlara neden olabilir. Aminoglikozidler geri dönüşsüz ototoksisite, nefrotoksisite ve nöromusküler blokaj riski taşır; kan düzeyi takibi önemlidir. Tetrasiklinler GİS irritasyonu ve hepatotoksisite; kloramfenikol fatal aplastik anemi ve neonatlarda Gri Bebek Sendromu; makrolidler kolestatik hepatit ve QT uzaması ile ilişkilidir. Antitüberküloz ilaçlarından izoniazid dirençli nöbetlere yol açıp pridoksin antidotu gerektirirken, rifampisin belirgin hepatotoksisiteye, etambutol ise optik nörite sebep olur. Diğer antibakteriyellerden klindamisin psödomembranöz kolit, vankomisin ise Kırmızı İnsan Sendromu ile öne çıkar. Genel olarak antibiyotik zehirlenmelerinde özgül antidotlar sınırlı olup temel yaklaşım ABCDE prensiplerine dayalı destek tedavisidir.
In this study addressing the toxicity and adverse effects of various antibiotic groups, it is stated that antibiotics generally possess a wide therapeutic window and fatal toxicity is rare. While sulfonamides can cause crystalluria, methemoglobinemia, and severe skin reactions, gastric lavage and methylene blue are recommended for treatment. Quinolones exhibit effects such as tendinitis, tendon rupture, QT prolongation, and CNS excitation. Penicillins, belonging to the beta-lactam group, carry risks of hypersensitivity, Hoigne syndrome, Jarisch-Herxheimer reaction, and seizures at high doses, whereas cephalosporins can cause disulfiram-like reactions. Aminoglycosides carry risks of irreversible ototoxicity, nephrotoxicity, and neuromuscular blockade, making blood level monitoring essential. Tetracyclines are associated with GI irritation and hepatotoxicity; chloramphenicol with fatal aplastic anemia and Gray Baby Syndrome in neonates; and macrolides with cholestatic hepatitis and QT prolongation. Among antitubercular drugs, isoniazid causes refractory seizures requiring pyridoxine as an antidote, while rifampicin leads to marked hepatotoxicity and ethambutol causes optic neuritis. Among other antibacterials, clindamycin is prominent for pseudomembranous colitis and vancomycin for Red Man Syndrome. Overall, specific antidotes in antibiotic poisonings are limited, and the primary approach relies on supportive care based on ABCDE principles.
References
Blanc W, Johnson L. Studıes ox kernıcterus: Relatıonshıp wıth sulfonamıde ıntoxıcatıon, report on kernıcterus ın rats wıth glucuronyl transferase defıcıency and revıew of pathogenesıs. Journal of Neuropathology and Experimental Neurology. 18(1):165–189, january 1959
Dibbern, D. A., & Montanaro, A. (2008). Allergies to sulfonamide antibiotics and sulfur-containing drugs. Annals of Allergy, Asthma & Immunology, 100(2), 91–101. doi:10.1016/s1081-1206(10)60415-2
Dunn, R. J. (1998). Massive Sulfasalazine and Paracetamol Ingestion Causing Acidosis, Hyperglycemia, Coagulopathy, and Methemoglobinemia. Journal of Toxicology: Clinical Toxicology, 36(3), 239–242. doi:10.3109/15563659809028946
Wılton, L. V., Pearce, G. L., & Mann, R. D. (2003). A comparison of ciprofloxacin, norfloxacin, ofloxacin, azithromycin and cefixime examined by observational cohort studies. British Journal of Clinical Pharmacology, 41(4), 277–284. doi:10.1046/j.1365-2125.1996.03013.x
V V Pillay. Anti-İnfectives. In: V V Pillay Modern Medical Toxicology (4th Edition) . Jaypee Brothers Medıcal Publıshers (p) LTD; 2013: 430-464
Nykamp, D. L., Blackmon, C. L., Schmidt, P. E., & Roberson, A. G. (2005). QTc Prolongation Associated with Combination Therapy of Levofloxacin, Imipramine, and Fluoxetine. Annals of Pharmacotherapy, 39(3), 543–546. doi:10.1345/aph.1e513
Fuchs, S., Simon, Z., & Brezis, M. (1994). Fatal hepatic failure associated with ciprofloxacin. The Lancet, 343(8899), 738–739. doi:10.1016/s0140-6736(94)91624-1
Pierfitte C, Gillet P, Royer RJ(1995). More on fluoroquinolone antibiotics and tendon rupture. N Eng J Med 332:193
Connor, J. P., Curry, J. M., Selby, T. L., & Perlmutter, A. D. (1994). Acute Renal Failure Secondary to Ciprofloxacin Use. The Journal of Urology, 151(4), 975–976. doi:10.1016/s0022-5347(17)35139-x
Schluter, G. (1989). Ciprofloxacin: Toxicologic evaluation of additional safety data. The American Journal of Medicine, 87(5), S37–S39. doi:10.1016/0002-9343(89)90018-1
Kushner, J. M., Peckman, H. J., & Snyder, C. R. (2001). Seizures Associated with Fluoroquinolones. Annals of Pharmacotherapy, 35(10), 1194–1198. doi:10.1345/aph.10359
Hootkins R1, Fenves AZ, Stephens MK. (1989). Acute renal failure secondary to oral ciprofloxacin therapy: a presentation of three cases and a review of the literature. Clinical Nephrology, 32(2):75-78
Green, R. L., Lewis, J. E., Kraus, S. J., & Frederickson, E. L. (1974). Elevated Plasma Procaine Concentrations after Administration of Procaine Penicillin G. New England Journal of Medicine, 291(5), 223–226. doi:10.1056/nejm197408012910503
Ilechukwu, S T C.(1990). Acute Psychotic Reactions and Stress Response Syndromes Following Intramuscular Aqueous Procaine Penicillin. The British Journal of Psychiatry; London Vol. 156, Iss. 4, : 554-559. DOI:10.1192/bjp.156.4.554
Malone, J. D., Lebar, R. D., & Hilder, R. (1988). Procaine-induced Seizures After Intramuscular Procaine Penicillin G. Military Medicine, 153(4), 191–192. doi:10.1093/milmed/153.4.191
Stork CM. Antibacterials, Antifungals and Antivirals. In: Nelson L, Lewin N, Hoffman R, Goldfrank L, Flomenbaum N (Eds.). Goldfrank’s Toxicologic Emergencies (Ninth Edition). The Mcgraw-Hill ;2010: 817-834
Meislin, H. W., & Bremer, J. C. (1976). Jarisch-herxheimer reaction case report. Journal of the American College of Emergency Physicians, 5(10), 779–781. doi:10.1016/s0361-1124(76)80309-7
Negussie, Y. (1992). Detection of plasma tumor necrosis factor, interleukins 6, and 8 during the Jarisch-Herxheimer Reaction of relapsing fever. Journal of Experimental Medicine, 175(5), 1207–1212. doi:10.1084/jem.175.5.1207
Gresser U.(2001). Amoxıcıllın-clavulanıc acıd therapy may be assocıated wıth severe sıde effects – revıew of the lıterature. Eur J Med Res 6: 139-149
Walker, A. E. (1945). Convulsıve factor ın commercıal penıcıllın. Archives of Surgery, 50(2), 69. doi:10.1001/archsurg.1945.01230030074003
Brummett, R. E., & Fox, K. E. (1989). Aminoglycoside-induced hearing loss in humans. Antimicrobial Agents and Chemotherapy, 33(6), 797–800. doi:10.1128/aac.33.6.797
Paradelis A. G. , Triantaphyllidis C. , Logaras G. (1976). Neuromuscular Blocking Activity of Aminoglycoside Antibiotics. Pharmacology of Antibiotics Volume 4 pp 359-36
Begg EJ, Barclay ML. Aminoglycosides: 50 years on. Br J Clin Pharmacol 1995; 39: 597–603.
Cheng, E. Y., Nimphius, N., & Hennen, C. R. (1995). Antibiotic therapy and the anesthesiologist. Journal of Clinical Anesthesia, 7(5), 425–439. doi:10.1016/0952-8180(95)00034-f .
Le Prell, C. G., Ojano-Dirain, C., Rudnick, E., et al (2014). Assessment of Nutrient Supplement to Reduce Gentamicin-Induced Ototoxicity. Journal of the Association for Research in Otolaryngology. doi:10.1007/s10162-014-0448-x.
Carson, J. L. (1993). Acute Liver Disease Associated with Erythromycins, Sulfonamides, and Tetracyclines. Annals of Internal Medicine, 119(7_Part_1), 576. doi:10.7326/0003-4819-119-7_part_1-199310010-00005
Gordon, G. (1985). Hyperpigmentation of the Skin Associated With Minocycline Therapy. Archives of Dermatology, 121(5), 618. doi:10.1001/archderm.1985.01660050070017
Hunt, C. M., & Washington, K. (1994). Tetracycline-induced bile duct paucity and prolonged cholestasis. Gastroenterology, 107(6), 1844–1847. doi:10.1016/0016-5085(94)90830-3
Page, S. (1991). Chloramphenicol 1. Hazards of use and the current regulatory environment. Australian Veterinary Journal, 68(1), 1–2. doi:10.1111/j.1751-0813.1991.tb09826.x
Yunis AA. (1989). Chloramphenicol toxicity: 25 years of research. The American Journal of Medicine, 87(3N):44N-48N
30. Holt D , Harvey D, Hurley R. (1993). Chloramphenicol toxicity Adverse Drug React Toxicol Rev Summer 1993;12(2):83-95.
Bottenberg, M. M., Wall, G. C., & Hicklin, G. A. (2007). Apparent anaphylactoid reaction after treatment with a single dose of telithromycin. Annals of Allergy, Asthma & Immunology, 98(1), 89–91. doi:10.1016/s1081-1206(10)60865-4
Gilbert, F. I. (1962). Cholestatic Hepatitis Caused by Esters of Erythromycin and Oleandomycin. JAMA, 182(10). doi:10.1001/jama.1962.03050490072017d
Inman, W. H., & Rawson, N. S. (1983). Erythromycin estolate and jaundice. BMJ, 286(6382), 1954–1955. doi:10.1136/bmj.286.6382.1954
Gorelik, E., Masarwa, R., Perlman, A., Rotshild, V., Muszkat, M., & Matok, I. (2018). Systematic Review, Meta-analysis, and Network Meta-analysis of the Cardiovascular Safety of Macrolides. Antimicrobial Agents and Chemotherapy, 62(6). doi:10.1128/aac.00438-18
G Danan, V Descatoire and D Pessayre (1981). Self-induction by erythromycin of its own transformation into a metabolite forming an inactive complex with reduced cytochrome P-450. Journal of Pharmacology and Experimental Therapeutics August 218 (2) 509-514;
Pai, M. P., Graci, D. M., & Amsden, G. W. (2000). Macrolide Drug Interactions: An Update. Annals of Pharmacotherapy, 34(4), 495–513. doi:10.1345/aph.19138
Rao RB. Isoniazid (INH) poisoning www.uptodate.com 2019.
Badrinath M, John S. Isoniazid Toxicity. In: StatPearls. StatPearls Publishing, Treasure Island (FL); 2020
Meisel S, Brower R (1980) Rifampicin: a suicidal dose. Ann Intern Med 92: 262
Hermon CH, Boyer EH. Antituberculous Medications. In: Nelson L, Lewin N, Hoffman R, Goldfrank L, Flomenbaum N (Eds.). Goldfrank’s Toxicologic Emergencies (Ninth Edition). The Mcgraw-Hill ;2010: 834-840
Lee N, Nguyen H. Ethambutol. [Updated 2020 Jun 10]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2020 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK559050/
Alex Melamud, Gregory S. Kosmorsky, Michael S. Lee, Ocular Ethambutol Toxicity, Mayo Clinic Proceedings, Volume 78, Issue 11, 2003, Pages 1409-1411, ISSN 0025-6196, https://doi.org/10.4065/78.11.1409.
Dhawan, V. K., & Thadepalli, H. (1982). Clindamycin: A Review of Fifteen Years of Experience. Clinical Infectious Diseases, 4(6), 1133–1153. doi:10.1093/clinids/4.6.1133
Parry, M. F. (1986). Pseudomembranous Colitis Caused by Topical Clindamycin Phosphate. Archives of Dermatology, 122(5), 583. doi:10.1001/archderm.1986.01660170113031 .
Spížek, J., Řezanka, T. Lincomycin, clindamycin and their applications. Appl Microbiol Biotechnol 64, 455–464 (2004). https://doi.org/10.1007/s00253-003-1545-7
Stidham, T., Reiter, P. D., Ford, D. M., Lum, G. M., & Albietz, J. (2011). Successful Utilization of High-Flux Hemodialysis for Treatment of Vancomycin Toxicity in a Child. Case Reports in Pediatrics, 2011, 1–4. doi:10.1155/2011/678724
O’Sullivan, T. L., Ruffing, M. J., Lamp, K. C., Warbasse, L. H., & Rybak, M. J. (1993). Prospective Evaluation of Red Man Syndrome in Patients Receiving Vancomycin. Journal of Infectious Diseases, 168(3), 773–776. doi:10.1093/infdis/168.3.773
Mellor, J. A., Kingdom, J., Cafferkey, M., & Keane, C. T. (1985). Vancomycin toxicity: a prospective study. Journal of Antimicrobial Chemotherapy, 15(6), 773–780. doi:10.1093/jac/15.6.773